Your browser doesn't support javascript.
loading
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignancies.
Savona, Michael R; Kolibaba, Kathryn; Conkling, Paul; Kingsley, Edwin C; Becerra, Carlos; Morris, John C; Rifkin, Robert M; Laille, Eric; Kellerman, Amy; Ukrainskyj, Stacey M; Dong, Qian; Skikne, Barry S.
Afiliação
  • Savona MR; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Kolibaba K; US Oncology Research, Woodlands, Texas.
  • Conkling P; Northwest Cancer Specialists, Vancouver, Western Australia.
  • Kingsley EC; US Oncology Research, Woodlands, Texas.
  • Becerra C; Virginia Oncology Associates, Norfolk, Virginia.
  • Morris JC; US Oncology Research, Woodlands, Texas.
  • Rifkin RM; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.
  • Laille E; US Oncology Research, Woodlands, Texas.
  • Kellerman A; Texas Oncology, PA (North), Sammons Cancer Center, Dallas, Texas.
  • Ukrainskyj SM; University of Cincinnati Cancer Institute, Cincinnati, Ohio.
  • Dong Q; US Oncology Research, Woodlands, Texas.
  • Skikne BS; Rocky Mountain Cancer Centers, Denver, Colorado.
Am J Hematol ; 93(10): 1199-1206, 2018 10.
Article em En | MEDLINE | ID: mdl-30016552

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article